Belluscura signs distribution agreement
By HME News Staff
Updated 10:43 AM CDT, Thu September 22, 2022
LONDON and PLANO, Texas – Belluscura has signed a distribution agreement with a leading DME provider and distributor in the United States, it has announced. Belluscura, which makes the X-PLOR portable oxygen concentrator, says the DME provider has been supplying home oxygen therapy for more than 50 years through 1,000 brick-and-mortar locations throughout the country, as well as online. “This agreement, with one of the largest supplemental oxygen providers in the U.S., significantly increased our coverage across the country and will give more patients access to our best-in class devices,” said Robert Rauker, CEO of Belluscura. The agreement is for distribution of the next-generation X-PLOR, which features the company’s new Nomad Biometric app. The app allows patients to connect other Bluetooth devices, pulse oximeters and wearables.
Comments